The Role of PTEN Loss in Immune Escape, Melanoma Prognosis and Therapy Response

The Role of PTEN Loss in Immune Escape, Melanoma Prognosis and Therapy Response

Checkpoint blockade therapies have changed the clinical management of metastatic melanoma patients considerably, showing survival benefits. Despite the clinical success, not all patients respond to treatment or they develop resistance. Although there are several treatment predictive biomarkers, unde...

Full description

Bibliographic Details
Main Authors: Rita Cabrita, Shamik Mitra, Adriana Sanna, Henrik Ekedahl, Kristina Lövgren, Håkan Olsson, Christian Ingvar, Karolin Isaksson, Martin Lauss, Ana Carneiro, Göran Jönsson
Format: Article
Language:English
Published: MDPI AG 2020-03-01
Series:Cancers
Subjects:
melanoma
pten
immune evasion
Online Access:https://www.mdpi.com/2072-6694/12/3/742

Internet

https://www.mdpi.com/2072-6694/12/3/742

Similar Items